May 24-26, 2021 | 8:00AM EDT | 12:00PM UTC | 2:00PM CEST*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
Injury-induced Damage Associated Molecular Patterns (DAMPs) are beginning to shape modern medicine in the field of both diagnostics and therapeutics. For example, DAMPs are already recognized to be major contributors to rejection in the field of transplantation, and efforts are underway to target them. Research is showing that they can also contribute to rejection of tumors, for example with immunogenic cell death, and efforts are underway to stimulate them for cancer eradication. With their use, new vaccination modalities will be developed against viral infections, including HIV and ZIKA virus.
Further, DAMPs-based innovative diagnostic methods and new therapeutic strategies will soon improve survival rates of critically ill patients, such as those who have undergone major trauma. Due to its involvement in autoimmune diseases, chronic inflammatory diseases, and allergic diseases, as well as plant resistance to predators, initiation of innate immune responses by DAMPs is currently a thriving research area. It covers both medical and agricultural fields. The goal of this conference is to convene internationally renowned experts from academia, biotech and pharma, in fields reflecting the diversity listed above, to present and discuss their latest findings in DAMPs research and applications.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: May 13, 2021
Financial Aid Application: Passed
*Abstract submission is required in order to submit an ePoster and/or Scitalk
Ecole Polytechnique Fédérale de Lausanne, Switzerland
Christoph J. Binder
Medical University of Vienna, Austria
Julie Magarian Blander
Cornell University, USA
Zhijian "James" Chen
University of Texas Southwestern, USA
Sara R. Cherry
University of Pennsylvania, USA
Giulia De Lorenzo
University of Rome, Sapienza, Italy
Douglas R. Green
St. Jude Children's Research Hospital, USA
Michael T. Heneka
German Center for Neurodegenerative Diseases, Germany
Harvard Medical School, USA
Jae U. Jung
Keck School of Medicine of University of Southern California, USA
Jonathan C. Kagan
Boston Children's Hospital, USA
BioNTech RNA Pharmaceuticals, Germany
University of Bonn, Germany
Medical Clinic MKIII, Germany
NIAID, National Institutes of Health, USA
Caetano Reis e Sousa
Francis Crick Institute, UK
Goethe University, Germany
University of Queensland, Australia
Seoul National University, South Korea
Radboud University Medical Center, Netherlands
Harvard Medical School, USA
Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.